3.48
3.48 (0%)
As of Apr 25, 2025
Qualigen Therapeutics, Inc. [QLGN]
Source:
Company Overview
Qualigen Therapeutics, Inc is a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drugdesignation, while also commercializing diagnostics.
| Country | United States |
| Headquarters | california, california |
| Phone Number | (760) 918-9165 |
| Industry | manufacturing |
| CEO | Michael S. Poirier |
| Website | www.qualigeninc.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-1.4 |
| Net Income | $-2 |
| Net Cash | $-0.3 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | 0 |
| Profit as % of Revenues | 0% |
| Profit as % of Assets | -133.9% |
| Profit as % of Stockholder Equity | 0% |
Management Effectiveness
| Return on Equity | 0% |
| Return on Assets | -0.2% |
| Turnover Ratio | 0% |
| EBITA | $-1.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1 |
| Total Liabilities | $4.5 |
| Operating Cash Flow | $-0.8 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.5 |
